Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-25 @ 4:18 AM
NCT ID:
NCT01343420
Eligibility Criteria:
Inclusion Criteria:
* Patients must sign informed consent before completing any study procedure.
* Age 18 years and ≤60 years.
* Dog-sensitized patients as indicated by a mean wheal \> 5 mm with the AP dog extract.
* Females of child-bearing potential must have a negative pregnancy test the day of skin testing.
* Patients who are able to understand the information given and be compliant with the protocol.
Exclusion Criteria:
* Asthma requiring treatment with medications other than beta-2 inhaled agonists and montelukast inhibitors.
* Patients with a history of asthma or wheezing with an FEV1 \<80%.
* Subjects who have taken an ocular or nasal antihistamine within 5 days prior to the procedures.
* Patients who have received any desensitization for dog allergen in the past 5 years.
* Patients with any past or current clinically significant condition that may affect the patient's participation or the outcome of the study to the discretion of the investigator. These include, but are not limited to, anaphylaxis with cardio-respiratory symptoms, chronic urticaria and angioedema unless related to dog exposure, severe atopic dermatitis, malignancy, cardiovascular, hepatic, renal, hematological, neurological, immunological, and endocrine disease.
* Subjects taking beta blockers, ace inhibitors, continuous systemic corticotherapy, immunosuppressive drugs or monoamine oxidase inhibitors.
* Use of H1 antagonists, tricyclic antidepressants and phenothiazines within 5 days prior to the testing.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT01343420
Study Brief:
Protocol Section:
NCT01343420